Showing results (331-340 of 435) with videos related to
Sort By:
Pageof 44
The New England Journal of Medicine|May 30, 2025
Encorafenib, Cetuximab, and mFOLFOX6 in BRAF-Mutated Colorectal CancerElena Elez, Takayuki Yoshino, Lin Shen, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancerDaniel A Fox, Deepak Bhamidipati, Tsuyoshi Konishi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2021
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal CancerAmir Mehrvarz Sarshekeh, Jumanah Alshenaifi, Jason Roszik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastasesDan G Blazer, Yoji Kishi, Dipen M Maru, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.Nature Cell Biology|October 31, 2018
TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signallingYoun-Sang Jung, Sohee Jun, Moon Jong Kim, et al.Nature Cell Biology|December 1, 2025
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancerWarapen Treekitkarnmongkol, Hiroshi Katayama, Deivendran Sankaran, et al.Disease Models & Mechanisms|November 17, 2019
A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveriesOmkara Lakshmi Veeranki, Zhimin Tong, Alicia Mejia, et al.JCO Precision Oncology|September 14, 2020
Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional IndicationsEcaterina E Ileana Dumbrava, Kavitha Balaji, Kanwal Raghav, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2017
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal CancerChristine M Parseghian, Nila U Parikh, Ji Yuan Wu, et al.Pageof 44